Narrow Results

The article is about the development of biotechnology industry in Taiwan. It is an overview of the progress of the research and development in the biomedical sector in Taiwan.

The article is about the success story of jumpstarting genomic projects and participation in the Human Genome Project. It touches on international collaborations and the launch of the Rice Genome Project.

WHO Chapter.

Country Chapter — China, Hong Kong, Taiwan, Canada, Singapore, Vietnam.

Current and Emerging Diagnostic and Therapeutic Developments in Age-Related Macular Degeneration (AMD).

International Collaborative Research Program focusing on Aging.

Anterior Segment Optical Coherence Tomography Angiography (OCTA).

Clinical Trials in our Real World.

Ophthalmology Workforce Planning and Projection – A New Integrated Approach.

Professor Emmanuel Tsesmelis: is an experimental particle physicist with a career spanning scientific research, academic teaching, science communication, international relations and management at CERN and at several universities. He is a Senior Physicist and Deputy Head of International Relations in CERN's Director-General Unit and a Visiting Professor in Particle and Accelerator Physics at the University of Oxford. He is an elected Fellow of the Australian Institute of Physics and a supernumerary member of Jesus College, Oxford.

Professor Albert De Roeck: is a senior research scientist and staff member at CERN. He is also a professor at the University of Antwerp (Belgium) and a visiting professor at the Institute of Particle Physics and Phenomenology in Durham (UK). He obtained his PhD at the university of Antwerp on an experiment at CERN, studying the multiparticle dynamics in hadron-hadron interactions, by colliding meson beams on protons and nuclear targets. After his PhD, Albert spent 10 years at the German particle physics laboratory, DESY, where he and his team made very precise measurements of the quark and gluon structure of the proton. In the late 90's his interest turned to the possibility to discover new physics, in particular Supersymmetry and Extra Dimensions, and he returned to CERN and joined an experiment at the large electron-positron collider LEP. Albert is now one the leaders of the physics program and preparation for physics analysis at the CMS experiment at the LHC.

Although human embryonic stem cells may have enormous potential for the treatment of degenerative diseases, their origins and derivation have raised unprecedented controversy in many societies. Many organisations, on both international and national levels, have responded with regulatory systems that seek to manage and supervise such work. These systems vary from voluntary professional guidelines and international treaties to government agencies and binding national legislation. This chapter briefly summarises the main controversies surrounding human embryonic stem cell research and the existing international mechanisms that address its conduct. We then offer a more detailed overview of the relevant regulatory structures of five nations — the US, the UK, China, India and South Korea — where research with human embryonic stem cells is commonly practiced. A review of the responsible state and professional bodies in each country is included, along with a brief discussion of any relevant legislation. Regulations relevant to the conduct of international collaboration with national research groups are included where possible.

High Energy Physic in China can be classified into four major categories: accelerator-based experiments, underground experiments, surface experiments particularly at high altitude, and space experiments. An overview of these experiments and their future prospects are presented.